Gene therapy for retinal dystrophy: The Lancet: January 5, 2018
The Lancet in conversation with - Un podcast de The Lancet Group - Les vendredis
Catégories:
Rebecca Cooney discusses the newly FDA-approved gene therapy for treating loss of vision as a result of retinal dystrophy. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
